| 000 | 01784 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516071436.0 | ||
| 264 | 0 | _c20120622 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1096-9896 | ||
| 024 | 7 |
_a10.1002/path.3979 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBusacca, Sara | |
| 245 | 0 | 0 |
_aBRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma. _h[electronic resource] |
| 260 |
_bThe Journal of pathology _cJun 2012 |
||
| 300 |
_a200-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aMesothelioma _xgenetics |
| 650 | 0 | 4 |
_aPleural Neoplasms _xgenetics |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aVinblastine _xanalogs & derivatives |
| 650 | 0 | 4 | _aVinorelbine |
| 700 | 1 | _aSheaff, Michael | |
| 700 | 1 | _aArthur, Kenneth | |
| 700 | 1 | _aGray, Steven G | |
| 700 | 1 | _aO'Byrne, Kenneth J | |
| 700 | 1 | _aRichard, Derek J | |
| 700 | 1 | _aSoltermann, Alex | |
| 700 | 1 | _aOpitz, Isabelle | |
| 700 | 1 | _aPass, Harvey | |
| 700 | 1 | _aHarkin, D Paul | |
| 700 | 1 | _aQuinn, Jennifer E | |
| 700 | 1 | _aFennell, Dean A | |
| 773 | 0 |
_tThe Journal of pathology _gvol. 227 _gno. 2 _gp. 200-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/path.3979 _zAvailable from publisher's website |
| 999 |
_c21411117 _d21411117 |
||